Finance

Lists
Why is NEU down 2.79%?
Dive Deeper
NEU:ASX
Neuren Pharmaceuticals Ltd
A$23.00
-2.79%
(-0.66) 1D
Nov 13, 4:10:12 PM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NEU...
Open
A$23.09
High
A$23.48
Low
A$22.95
Mkt. cap
2.92B
Avg. vol.
421.84K
Volume
295.74K
Dividend
0.65%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
148.99
52-wk high
A$24.55
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$23.09
High
A$23.48
Low
A$22.95
Mkt. cap
2.92B
Avg. vol.
421.84K
Volume
295.74K
Dividend
0.65%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
148.99
52-wk high
A$24.55
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
ING Sprinters
ING Sprinters
·
2 days ago
De AEX Index blijft voortmodderen
ZeelandNet, startpagina van Zeeland
ZeelandNet, startpagina van Zeeland
·
11 hours ago
AEX-index begint voorzichtig door onrust rond Nvidia
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
18.19M
18.19M
16.58M
16.58M
Cost of goods sold
10.75M
10.75M
13.71M
13.71M
Cost of revenue
10.75M
10.75M
13.71M
13.71M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.87M
1.87M
1.51M
1.51M
Operating expense
1.87M
1.87M
1.51M
1.51M
Total operating expenses
12.62M
12.62M
15.22M
15.22M
Operating income
5.57M
5.57M
1.36M
1.36M
Other non operating income
-337.50K
-337.50K
-2.35M
-2.35M
EBT including unusual items
9.60M
9.60M
3.80M
3.80M
EBT excluding unusual items
9.60M
9.60M
3.80M
3.80M
Income tax expense
1.90M
1.90M
1.38M
1.38M
Effective tax rate
19.80%
19.80%
36.21%
36.21%
Other operating expenses
-
-
-
-
Net income
7.70M
7.70M
2.43M
2.43M
Net profit margin
42.35%
42.35%
14.63%
14.63%
Earnings per share
-
-
-
-
Interest and investment income
2.93M
2.93M
2.78M
2.78M
Interest expense
-
-
-
-
Net interest expenses
2.93M
2.93M
2.78M
2.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.58M
5.58M
1.37M
1.37M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps